对丁酸氯维地平这种药物的致癌风险的长期研究尚未进行。
Long-term studies for evaluation of carcinogenic potential have not been performed with clevidipine butyrate.
结论：卡维地洛联合贝那普利治疗慢性充血性心力衰竭疗效优于联合氨氯地平，预后较好。
Conclusion: the treatment with carvedilol combined with Benazepril to treat the CHF patients is better the combined with amlodipine, the prognosis is better.
应用推荐